L&C Bio Co., Ltd (290650.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap1.5T
Enterprise Value1.57T
P/E Ratio-11.51
PEG Ratio0.04
Price/Sales Ratio9.88
Price/Book Ratio4.21
Enterprise/Revenue10.08
Enterprise/EBITDA60.46

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.7
Operating Margin0.2
AD

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.38

Income Statement

Revenue85.48B
Revenue/Share2,074.79
Gross Profit41.32B
EBITDA11.57B
Net Income-138.17B
Diluted EPS-2,905.7

Balance Sheet

Total Cash41.53B
Total Cash/Share651.88
Total Debt63.77B
Total Debt/Equity0.2
Current Ratio1.33
Book Value Per Share5,260.81

Price History

52-Week Change-14.54
52-Week High62,500
52-Week Low20,380.56
Moving Average 50 Days25,825
Moving Average 200 Days32,909.03

Statistics

Average Volume503,824
Shares Outstanding60.87M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate24.18
Trailing Annual Dividend Yield0.11
Payout Ratio-0.01
Last Split Factor2:1
Last Split DateOctober 26, 2026
AD